Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti‐infliximab formation

OBJECTIVES: Correlation of serum trough infliximab levels and antibodies to infliximab (anti‐infliximab) with clinical response in ankylosing spondylitis. METHODS: In accordance with the international ASsessment in Ankylosing Spondylitis (ASAS) consensus statement, patients were treated with inflixi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: de Vries, Mirjam K, Wolbink, Gerrit Jan, Stapel, Steven O, de Vrieze, Henk, van Denderen, J Christiaan, Dijkmans, Ben A C, Aarden, Lucien A, van der Horst‐Bruinsma, Irene E
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2007
Témata:
Concise Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955152/
https://ncbi.nlm.nih.gov/pubmed/17472991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.072397
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky